John H. Kimbrough

509 total citations
29 papers, 345 citations indexed

About

John H. Kimbrough is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology. According to data from OpenAlex, John H. Kimbrough has authored 29 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Medicine, 12 papers in Pharmacology and 12 papers in Applied Microbiology and Biotechnology. Recurrent topics in John H. Kimbrough's work include Antibiotic Resistance in Bacteria (20 papers), Antibiotic Use and Resistance (12 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). John H. Kimbrough is often cited by papers focused on Antibiotic Resistance in Bacteria (20 papers), Antibiotic Use and Resistance (12 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). John H. Kimbrough collaborates with scholars based in United States and Japan. John H. Kimbrough's co-authors include Hélio S. Sader, Mariana Castanheira, Rodrigo E. Mendes, Eric V. Stabb, Linda L. McCarter, Cecília G Carvalhaes, J. Thomas Cribbs, Jeffrey L. Bose, Leonard R Duncan and Nicole E. Smalley and has published in prestigious journals such as Applied and Environmental Microbiology, Scientific Reports and Journal of Bacteriology.

In The Last Decade

John H. Kimbrough

25 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John H. Kimbrough United States 12 188 147 139 90 82 29 345
Jintao He China 13 368 2.0× 137 0.9× 150 1.1× 59 0.7× 28 0.3× 38 454
Irina Sánchez-Diener Spain 10 247 1.3× 145 1.0× 65 0.5× 84 0.9× 45 0.5× 10 301
Yuchen Wu China 11 206 1.1× 71 0.5× 90 0.6× 54 0.6× 41 0.5× 37 291
Konstantina Dafopoulou Greece 9 396 2.1× 86 0.6× 132 0.9× 154 1.7× 71 0.9× 10 437
Belita N. A. Opene United States 10 272 1.4× 87 0.6× 124 0.9× 63 0.7× 32 0.4× 12 358
Noémie Mayer France 8 257 1.4× 69 0.5× 136 1.0× 62 0.7× 24 0.3× 10 299
Changrui Qian China 12 173 0.9× 133 0.9× 70 0.5× 32 0.4× 15 0.2× 41 328
Steven J. Hancock Australia 10 212 1.1× 79 0.5× 136 1.0× 25 0.3× 13 0.2× 15 323
Tsukasa Horiyama Japan 8 221 1.2× 111 0.8× 109 0.8× 51 0.6× 15 0.2× 10 334

Countries citing papers authored by John H. Kimbrough

Since Specialization
Citations

This map shows the geographic impact of John H. Kimbrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Kimbrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Kimbrough more than expected).

Fields of papers citing papers by John H. Kimbrough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Kimbrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Kimbrough. The network helps show where John H. Kimbrough may publish in the future.

Co-authorship network of co-authors of John H. Kimbrough

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Kimbrough. A scholar is included among the top collaborators of John H. Kimbrough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Kimbrough. John H. Kimbrough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castanheira, Mariana, Lalitagauri M. Deshpande, John H. Kimbrough, & Marisa Winkler. (2025). Activity of Rezafungin Against Echinocandin Non–wild type Candida glabrata Clinical Isolates From a Global Surveillance Program. Open Forum Infectious Diseases. 12(3). ofae702–ofae702.
2.
3.
Sader, Hélio S., John H. Kimbrough, Marisa Winkler, Mariana Castanheira, & Rodrigo E. Mendes. (2025). Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019–2023). Journal of Antimicrobial Chemotherapy. 80(8). 2070–2079. 2 indexed citations
4.
Sader, Hélio S., John H. Kimbrough, Rodrigo E. Mendes, & Mariana Castanheira. (2024). Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales. BMC Infectious Diseases. 24(1). 1242–1242. 4 indexed citations
5.
Winkler, Marisa, et al.. (2024). Use of voriconazole to predict susceptibility and resistance to isavuconazole for Aspergillus fumigatus using CLSI methods and interpretive criteria. Journal of Clinical Microbiology. 63(2). e0120724–e0120724. 2 indexed citations
6.
Sader, Hélio S., Cecília G Carvalhaes, John H. Kimbrough, Rodrigo E. Mendes, & Mariana Castanheira. (2024). Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020–2022). International Journal of Antimicrobial Agents. 63(4). 107113–107113. 14 indexed citations
7.
Castanheira, Mariana, et al.. (2024). In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial Agents and Chemotherapy. 68(5). e0136323–e0136323. 7 indexed citations
8.
Grant, Lindsay R., Lalitagauri M. Deshpande, John H. Kimbrough, et al.. (2024). Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011–2021. Frontiers in Pediatrics. 12. 1383748–1383748. 3 indexed citations
9.
Kimbrough, John H., Joshua Maher, Hélio S. Sader, Mariana Castanheira, & Rodrigo E. Mendes. (2024). In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals. Microbiology Spectrum. 12(11). e0147424–e0147424. 5 indexed citations
10.
11.
12.
Sader, Hélio S., Rodrigo E. Mendes, Leonard R Duncan, et al.. (2023). Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022). Diagnostic Microbiology and Infectious Disease. 106(2). 115945–115945. 23 indexed citations
13.
14.
Abisado, Rhea G., et al.. (2021). Tobramycin Adaptation Enhances Policing of Social Cheaters in Pseudomonas aeruginosa. Applied and Environmental Microbiology. 87(12). e0002921–e0002921. 13 indexed citations
15.
16.
Kimbrough, John H., J. Thomas Cribbs, & Linda L. McCarter. (2020). Homologous c-di-GMP-Binding Scr Transcription Factors Orchestrate Biofilm Development in Vibrio parahaemolyticus. Journal of Bacteriology. 202(6). 38 indexed citations
17.
Kimbrough, John H. & Eric V. Stabb. (2017). Comparative analysis reveals regulatory motifs at the ainS/ainR pheromone-signaling locus of Vibrio fischeri. Scientific Reports. 7(1). 11734–11734. 7 indexed citations
18.
Kimbrough, John H. & Eric V. Stabb. (2015). Antisocial luxO Mutants Provide a Stationary-Phase Survival Advantage in Vibrio fischeri ES114. Journal of Bacteriology. 198(4). 673–687. 16 indexed citations
19.
Bose, Jeffrey L., et al.. (2013). Cyclic AMP Receptor Protein Regulates Pheromone-Mediated Bioluminescence at Multiple Levels in Vibrio fischeri ES114. Journal of Bacteriology. 195(22). 5051–5063. 27 indexed citations
20.
Kimbrough, John H. & Eric V. Stabb. (2013). Substrate Specificity and Function of the Pheromone Receptor AinR in Vibrio fischeri ES114. Journal of Bacteriology. 195(22). 5223–5232. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jintao He Breakdown of academic impact, for papers by Irina Sánchez-Diener Breakdown of academic impact, for papers by Yuchen Wu Breakdown of academic impact, for papers by Konstantina Dafopoulou Breakdown of academic impact, for papers by Belita N. A. Opene Breakdown of academic impact, for papers by Noémie Mayer Breakdown of academic impact, for papers by Changrui Qian Breakdown of academic impact, for papers by Steven J. Hancock Breakdown of academic impact, for papers by Tsukasa Horiyama
Rankless by CCL
2026